Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)

CUSIP: 71880W501

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+175,775
SEC-reported price per share
$1.05
Number of holders
17
Value change
+$184,258
Number of buys
13
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
12,067,869

Security key

71880W501

Report period

Q4 2025

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
CVI Investments, Inc.
Comparable rows
3/15
Latest evidence
31 Dec 2025
13D/G 3/4/5 13F Lead comparable stake: 9.9% 12 rows are not safely comparable across share classes. 13D/G row: CVI Investments, Inc. Showing 1-6 of 15 holder rows.

Quick read

CVI Investments, Inc. leads the comparable SEC ownership view at 9.9%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CVI Investments, Inc.'s linked filing trail.
Comparable ownership Top 3
CVI Investments, Inc. 9.9%
INTRACOASTAL CAPITAL, LLC 9.1%
Orca Capital AG 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CVI Investments, Inc.
13D/G
9.9%
Reported 13D/G · 31 Dec 2025
$1,409,768
1,194,719 shares
+$544,422 31 Dec 2025
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
9.1%
Reported 13D/G · 31 Dec 2025
$1,348,216
1,142,556 shares
+$840,816 31 Dec 2025
Orca Capital AG
13D/G
4.9%
Reported 13D/G · 08 Dec 2025
$770,351
538,707 shares
-$231,251 08 Dec 2025
Gerrit Dispersyn
3/4/5
President & CEO, Director
—
denominator unverified
$320,614
212,327 shares
— 01 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$217,317
87,628 shares
— 30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$143,605
57,906 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
363,848
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
11
Q4 2025 holders
17
Holder diff
6
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .